Related Experiment Video

Updated: May 19, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Identification and characterization of receptor-specific peptides for siRNA delivery

Yin Ren1, Sabine Hauert, Justin H Lo

  • 1Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

ACS Nano
|August 23, 2012
PubMed

Insights

Researchers developed targeted peptide-siRNA nanocomplexes for specific cancer cell delivery. These complexes overcome limitations of cell-penetrating peptides, enabling precise RNA interference therapy.

Area of Science:

  • Biotechnology and Nanomedicine
  • Molecular and Cellular Biology
  • Drug Delivery Systems

Background:

  • Tumor-targeted delivery of small interfering RNA (siRNA) is crucial for RNA interference (RNAi) therapeutics but remains a significant challenge.
  • Cell-penetrating peptides (CPPs) facilitate cellular uptake of siRNA but lack specificity, leading to off-target effects.

Purpose of the Study:

  • To design and screen novel tandem peptides combining tumor-targeting and cell-penetrating functionalities for specific siRNA delivery.
  • To develop stable siRNA nanocomplexes with enhanced cellular uptake, endosomal escape, and cytosolic delivery.
  • To elucidate structure-activity relationships governing receptor-specific siRNA delivery.

Main Methods:

  • Design and screening of a peptide library featuring tumor-targeting ligands and CPPs.
  • Formation of stable siRNA nanocomplexes and their physiochemical characterization.
  • Biological evaluation of nanocomplex uptake, endosomal escape, and siRNA delivery via endocytosis.
  • Computational regression analysis to identify key structural determinants for receptor-specific delivery.

Main Results:

  • A subset of designed nanocomplexes demonstrated receptor-specific cellular uptake via endocytosis.
  • These nanocomplexes successfully facilitated endosomal escape and siRNA release into the cytosol.
  • Computational analysis identified targeting ligand valence and peptide charge as critical factors for cell-specific delivery.
  • Ubiquitous CPPs were transformed into cell type-specific siRNA delivery systems.

Conclusions:

  • Tandem tumor-targeting and cell-penetrating peptides can form effective siRNA nanocomplexes for cell-specific delivery.
  • Understanding structure-activity relationships allows for the rational design of targeted nanomedicines.
  • This approach offers a promising strategy to enhance the therapeutic efficacy and safety of RNA interference.

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...